Lista de obras -

A meta-analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma ⬇️

artículo científico publicado el 30 de enero de 1998

A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel

artículo científico publicado en 2011

Access and response to direct antiviral agents (DAA) in HIV-HCV co-infected patients in Italy: Data from the Icona cohort

artículo científico publicado en 2017

Access to treatment for HBV infection and its consistency with 2008 European guidelines in a multicentre cross-sectional study of HIV/HBV co-infected patients in Italy

artículo científico publicado en 2013

Active HCV Replication but Not HCV or CMV Seropositive Status Is Associated With Incident and Prevalent Type 2 Diabetes in Persons Living With HIV.

artículo científico publicado en 2017

An update on integrase inhibitors: new opportunities for a personalized therapy? The NEXTaim Project

artículo científico publicado en 2015

Antiretroviral therapy in chronic liver disease: focus on HIV/HCV coinfection--statements of the First Italian Consensus Workshop

artículo científico publicado en 2005

Care of HIV patients with chronic hepatitis B: updated recommendations from the HIV-Hepatitis B Virus International Panel.

artículo científico publicado en 2008

Care of patients coinfected with HIV and hepatitis C virus: 2007 updated recommendations from the HCV-HIV International Panel

artículo científico publicado en 2007

Care of patients with chronic hepatitis B and HIV co-infection: recommendations from an HIV-HBV International Panel

artículo científico publicado en 2005

Circulating sCD14 is associated with virological response to pegylated-interferon-alpha/ribavirin treatment in HIV/HCV co-infected patients

artículo científico publicado en 2012

Clinical experiences with interferon as monotherapy or in combination with ribavirin in patients co-infected with HIV and HCV.

artículo científico publicado en 2002

Clinical management of drug-drug interactions in HCV therapy: challenges and solutions

artículo científico publicado en 2012

Coinfection with hepatitis viruses and outcome of initial antiretroviral regimens in previously naive HIV-infected subjects

artículo científico publicado en 2002

Comment to the editorial: Liver biopsy in HIV-infected patients with chronic hepatitis C: pros and cons, by Vincent Soriano and Javier García-Samaniego

artículo científico publicado en 2002

Comparison of three therapeutic regimens for genotype-3 hepatitis C virus infection in a large real-life multicentre cohort

artículo científico publicado en 2020

Cytopenias during treatment of HIV-HCV-coinfection with pegylated interferon and ribavirin: safety analysis of the OPERA study

artículo científico publicado en 2014

Daclatasvir-based regimens in HCV cirrhosis: experience from the Italian early access program

artículo científico publicado en 2019

Detection of Serum Hepatitis C Virus RNA in Acute Non-A, Non-B Hepatitis ⬇️

artículo científico publicado el 1 de abril de 1991

Development and validation of a prediction model for severe respiratory failure in hospitalized patients with SARS-Cov-2 infection: a multicenter cohort study (PREDI-CO study)

artículo científico publicado en 2020

Durability and tolerability of first-line regimens including two nucleoside reverse transcriptase inhibitors and raltegravir or ritonavir boosted-atazanavir or -darunavir: data from the ICONA Cohort

article by Antonella d'Arminio Monforte et al published April 2018 in HIV Clinical Trials

ELITA consensus statements on the use of DAAs in liver transplant candidates and recipients.

artículo científico publicado en 2017

Effectiveness and safety of glecaprevir/pibrentasvir in chronic hepatitis C patients: Results of the Italian cohort of a post-marketing observational study

scientific article published on 08 September 2020

Efficacy of corticosteroid treatment for hospitalized patients with severe COVID-19: a multicenter study

scientific article published on 21 September 2020

Evaluation of hepatitis delta virus RNA levels during interferon therapy by analysis of polymerase chain reaction products with a nonradioisotopic hybridization assay

artículo científico publicado el 1 de abril de 1992

Evolution of the prevalence of HCV infection and HCV genotype distribution in HIV-infected patients in Italy between 1997 and 2015.

artículo científico

Fast relapse and high drop out rate of 48 weeks daily interferon monotherapy in HIV-infected patients with chronic hepatitis C.

artículo científico publicado en 2002

Frequent hepatitis B virus rebound among HIV-hepatitis B virus-coinfected patients following antiretroviral therapy interruption

artículo científico publicado en 2010

HCV chronic hepatitis in patients with HIV: clinical management issues

artículo científico publicado en 2002

HCVerso1 and 2: faldaprevir with deleobuvir (BI 207127) and ribavirin for treatment-naïve patients with chronic hepatitis C virus genotype-1b infection.

artículo científico publicado en 2016

HIV-1 co-receptor tropism and liver fibrosis in HIV-infected patients

artículo científico publicado en 2018

HIV-related liver disease: ARV drugs, coinfection, and other risk factors

scientific article published on January 2009

Hepatitis A Virus in men who have sex with men: Need for awareness and vaccination

artículo científico publicado en 2018

Hepatitis B virus co-infection in human immunodeficiency virus-infected subjects.

artículo científico publicado en 2002

Hepatitis C virus RNA and antibody response in the clinical course of acute hepatitis C virus infection

artículo científico publicado el 1 de octubre de 1992

Hepatitis C virus infection after renal transplantation: prevalence and course of morphologic lesions ⬇️

artículo científico publicado el 1 de agosto de 1998

Hepatocellular carcinoma in HIV hepatitis C virus.

artículo científico publicado en 2011

Hepatocellular carcinoma in HIV-infected patients with chronic hepatitis: an emerging issue

artículo científico publicado en 2002

Heterogeneity of the Hepatitis C Virus Genome ⬇️

artículo científico publicado el 1 de junio de 1991

High sustained virologic response rates in rapid virologic response patients in the large real-world PROPHESYS cohort confirm results from randomized clinical trials ⬇️

artículo científico publicado el 8 de agosto de 2012

Hyaluronic acid levels predict increased risk of non-AIDS death in hepatitis-coinfected persons interrupting antiretroviral therapy in the SMART Study

artículo científico publicado en 2011

Hyperglycemia in severe falciparum malaria: a case report

artículo científico publicado en 2012

Immune activation and microbial translocation in liver disease progression in HIV/hepatitis co-infected patients: results from the Icona Foundation study

artículo científico publicado en 2014

Impact of hepatitis C virus infection on lifestyle

artículo científico publicado en 2007

Impact of immunosuppressive therapy on the severity of COVID-19 in solid organ transplant recipients

scientific article published on 27 October 2020

Impact of lamivudine on the risk of liver-related death in 2,041 HBsAg- and HIV-positive individuals: results from an inter-cohort analysis

artículo científico publicado en 2006

Improvement of ALT decay kinetics by all-oral HCV treatment: Role of NS5A inhibitors and differences with IFN-based regimens

artículo científico publicado en 2017

Incidence and predictors of single drug discontinuation according to the presence of HCV coinfection in HIV patients from the ICONA Foundation Cohort Study

artículo científico publicado en 2018

Incidence and risk factors for liver enzyme elevation during highly active antiretroviral therapy in HIV-HCV co-infected patients: results from the Italian EPOKA-MASTER Cohort

artículo científico publicado en 2005

Influence of genotype 3 hepatitis C coinfection on liver enzyme elevation in HIV-1-positive patients after commencement of a new highly active antiretroviral regimen: results from the EPOKA-MASTER Cohort

artículo científico publicado en 2006

Italian consensus Guidelines for the management of hepatitis B virus infections in patients with rheumatoid arthritis

artículo científico publicado en 2017

Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons

artículo científico publicado el 30 de abril de 2011

Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update 2011

artículo científico publicado el 31 de marzo de 2012

Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update 2015.

artículo científico publicado en 2016

Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update 2016.

artículo científico publicado en 2017

Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update December 2014.

artículo científico publicado en 2015

Lamivudine or emtricitabine (XTC)/protease inhibitor dual therapy as a harm-reduction strategy in patients with tenofovir-related renal toxicity: A case–control study ⬇️

artículo científico publicado el 17 de julio de 2012

Liver enzyme elevation during darunavir-based antiretroviral treatment in HIV-1-infected patients with or without hepatitis C coinfection: data from the ICONA foundation cohort

artículo científico publicado en 2014

Liver fibrosis, microbial translocation and immune activation markers in HIV and HCV infections and in HIV/HCV co-infection.

artículo científico publicado en 2014

Liver stiffness measurement by transient elastography predicts early recovery from acute hepatitis

article

Management of hepatocellular carcinoma in human immunodeficiency virus-infected patients

artículo científico publicado en 2005

Management of infections in cirrhotic patients: report of a consensus conference

artículo científico publicado en 2013

Management of infections pre- and post-liver transplantation: report of an AISF consensus conference

artículo científico publicado en 2013

Managing hepatitis C virus-HIV liver transplant recipients with the new direct-acting antivirals: are we glimpsing a brilliant future behind our shoulders?

artículo científico publicado en 2016

Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies

artículo científico publicado en 2017

Natural history of chronic hepatitis B in co-infected patients.

artículo científico publicado en 2005

Natural history of compensated viral cirrhosis in a cohort of patients with HIV infection

artículo científico publicado en 2007

News on Viral Hepatitis in HIV: Update from the 2016 GEHEP Conference

artículo científico publicado en 2017

Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study

artículo científico publicado en 2017

Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir Combination Treatment in Patients with HIV/HCV Co-Infection: Results of an Italian Compassionate Use Program

artículo científico publicado en 2016

Opportunistic disease and mortality in patients coinfected with hepatitis B or C virus in the strategic management of antiretroviral therapy (SMART) study

artículo científico publicado en 2008

Optimization of hepatitis C virus screening strategies by birth cohort in Italy

artículo científico publicado en 2020

Optimizing treatment in HIV/HCV coinfection

artículo científico

Pathogenesis of liver damage in HCV-HIV patients.

artículo científico publicado en 2008

Persistent positivity and fluctuations of SARS-CoV-2 RNA in clinically-recovered COVID-19 patients

artículo científico publicado en 2020

Prevalence of Single and Multiple Natural NS3, NS5A and NS5B Resistance-Associated Substitutions in Hepatitis C Virus Genotypes 1-4 in Italy

artículo científico publicado en 2018

Prise en charge de l’infection par le virus de l’hépatite B chez les patients atteints de polyarthrite rhumatoïde : conférence de consensus italienne

Prognostic Value of the Fibrosis-4 Index in Human Immunodeficiency Virus Type-1 Infected Patients Initiating Antiretroviral Therapy with or without Hepatitis C Virus

artículo científico publicado en 2015

Quantification of 1,3-β-D-Glucan by Wako β-Glucan Assay for rapid exclusion of invasive fungal infections in critical patients: a diagnostic test accuracy study

scientific article published on 18 August 2020

Rapid hepatitis B virus-DNA decay in co-infected HIV-hepatitis B virus 'e-minus' patients with YMDD mutations after 4 weeks of tenofovir therapy

artículo científico publicado en 2003

Real-life data on potential drug-drug interactions in patients with chronic hepatitis C viral infection undergoing antiviral therapy with interferon-free DAAs in the PITER Cohort Study

artículo científico publicado en 2017

Real-life effectiveness and safety of Glecaprevir/Pibrentasvir in 723 patients with chronic hepatitis C

scientific article published on 23 November 2018

Real-life effectiveness and safety of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients with previous DAA failure

artículo científico publicado en 2019

Recommendations for the management of mixed cryoglobulinemia syndrome in hepatitis C virus-infected patients

artículo científico publicado en 2011

Renal safety in 3264 HCV patients treated with DAA-based regimens: Results from a large Italian real-life study

scientific article published on 06 December 2019

Risk of developing specific AIDS-defining illnesses in patients coinfected with HIV and hepatitis C virus with or without liver cirrhosis

artículo científico publicado en 2009

Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals

artículo científico publicado en 2005

Sofosbuvir and Ribavirin for Treatment of Chronic Hepatitis C in Patients Coinfected With Hepatitis C Virus and HIV: The Impact on Patient-Reported Outcomes

scientific article published on 12 January 2015

Statements from the Taormina expert meeting on occult hepatitis B virus infection

artículo científico publicado en 2008

Strategies for assignment of HIV-HCV genotype-1-coinfected patients to either dual-therapy or direct-acting antiviral agent-based triple-therapy

artículo científico publicado en 2013

Successful Pre- and Posttransplant Sofosbuvir-Based Anti-Hepatitis C Virus Treatment in Persons Living With Human Immunodeficiency Virus Infection

article

The burden of HIV and hepatitis C virus coinfection

artículo científico publicado en 2007

The burden of liver disease in human immunodeficiency virus-infected patients

artículo científico

The epidemiological pattern of chronic liver diseases in a community undergoing voluntary screening for hepatitis B and C.

artículo científico publicado en 2011

The homeostasis model assessment of the insulin resistance score is not predictive of a sustained virological response in chronic hepatitis C patients ⬇️

artículo científico publicado el 14 de septiembre de 2010

The impact of interleukin 28B rs12979860 single nucleotide polymorphism and liver fibrosis stage on response-guided therapy in HIV/HCV-coinfected patients.

artículo científico publicado en 2013

The management of hepatitis B virus/HIV-1 co-infected patients starting their first HAART regimen. Treating two infections for the price of one drug?

artículo científico publicado en 2004

Treating hepatitis C virus in HIV patients: are side effects a real obstacle?

artículo científico publicado en 2007

Treatment of chronic hepatitis B: update of the recommendations from the 2007 Italian Workshop.

scientific article published on 26 January 2011

Treatment of chronic hepatitis D with interferon alpha-2b in patients with human immunodeficiency virus infection ⬇️

artículo científico publicado el 1 de julio de 1998

Trend of estimated glomerular filtration rate during ombistasvir/paritaprevir/ritonavir plus dasabuvir ± ribavirin in HIV/HCV co-infected patients

artículo científico publicado en 2018

Triglyceride/HDL ratio and its impact on the risk of diabetes mellitus development during ART.

artículo científico publicado en 2016

Understanding the Mechanisms of Fibrogenesis in HIV/HCV-Coinfected Patients: Implications for Clinical Practice

artículo científico publicado en 2015

Use of tumor necrosis factor-alpha-blocking agents in hepatitis B virus-positive patients: reports of 3 cases and review of the literature

artículo científico publicado en 2009

Lista de obras de

A meta-analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma ⬇️

A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel

Access and response to direct antiviral agents (DAA) in HIV-HCV co-infected patients in Italy: Data from the Icona cohort

Access to treatment for HBV infection and its consistency with 2008 European guidelines in a multicentre cross-sectional study of HIV/HBV co-infected patients in Italy

Active HCV Replication but Not HCV or CMV Seropositive Status Is Associated With Incident and Prevalent Type 2 Diabetes in Persons Living With HIV.

An update on integrase inhibitors: new opportunities for a personalized therapy? The NEXTaim Project

Antiretroviral therapy in chronic liver disease: focus on HIV/HCV coinfection--statements of the First Italian Consensus Workshop

Care of HIV patients with chronic hepatitis B: updated recommendations from the HIV-Hepatitis B Virus International Panel.

Care of patients coinfected with HIV and hepatitis C virus: 2007 updated recommendations from the HCV-HIV International Panel

Care of patients with chronic hepatitis B and HIV co-infection: recommendations from an HIV-HBV International Panel

Circulating sCD14 is associated with virological response to pegylated-interferon-alpha/ribavirin treatment in HIV/HCV co-infected patients

Clinical experiences with interferon as monotherapy or in combination with ribavirin in patients co-infected with HIV and HCV.

Clinical management of drug-drug interactions in HCV therapy: challenges and solutions

Coinfection with hepatitis viruses and outcome of initial antiretroviral regimens in previously naive HIV-infected subjects

Comment to the editorial: Liver biopsy in HIV-infected patients with chronic hepatitis C: pros and cons, by Vincent Soriano and Javier García-Samaniego

Comparison of three therapeutic regimens for genotype-3 hepatitis C virus infection in a large real-life multicentre cohort

Cytopenias during treatment of HIV-HCV-coinfection with pegylated interferon and ribavirin: safety analysis of the OPERA study

Daclatasvir-based regimens in HCV cirrhosis: experience from the Italian early access program

Detection of Serum Hepatitis C Virus RNA in Acute Non-A, Non-B Hepatitis ⬇️

Development and validation of a prediction model for severe respiratory failure in hospitalized patients with SARS-Cov-2 infection: a multicenter cohort study (PREDI-CO study)

Durability and tolerability of first-line regimens including two nucleoside reverse transcriptase inhibitors and raltegravir or ritonavir boosted-atazanavir or -darunavir: data from the ICONA Cohort

ELITA consensus statements on the use of DAAs in liver transplant candidates and recipients.

Effectiveness and safety of glecaprevir/pibrentasvir in chronic hepatitis C patients: Results of the Italian cohort of a post-marketing observational study

Efficacy of corticosteroid treatment for hospitalized patients with severe COVID-19: a multicenter study

Evaluation of hepatitis delta virus RNA levels during interferon therapy by analysis of polymerase chain reaction products with a nonradioisotopic hybridization assay

Evolution of the prevalence of HCV infection and HCV genotype distribution in HIV-infected patients in Italy between 1997 and 2015.

Fast relapse and high drop out rate of 48 weeks daily interferon monotherapy in HIV-infected patients with chronic hepatitis C.

Frequent hepatitis B virus rebound among HIV-hepatitis B virus-coinfected patients following antiretroviral therapy interruption

HCV chronic hepatitis in patients with HIV: clinical management issues

HCVerso1 and 2: faldaprevir with deleobuvir (BI 207127) and ribavirin for treatment-naïve patients with chronic hepatitis C virus genotype-1b infection.

HIV-1 co-receptor tropism and liver fibrosis in HIV-infected patients

HIV-related liver disease: ARV drugs, coinfection, and other risk factors

Hepatitis A Virus in men who have sex with men: Need for awareness and vaccination

Hepatitis B virus co-infection in human immunodeficiency virus-infected subjects.

Hepatitis C virus RNA and antibody response in the clinical course of acute hepatitis C virus infection

Hepatitis C virus infection after renal transplantation: prevalence and course of morphologic lesions ⬇️

Hepatocellular carcinoma in HIV hepatitis C virus.

Hepatocellular carcinoma in HIV-infected patients with chronic hepatitis: an emerging issue

Heterogeneity of the Hepatitis C Virus Genome ⬇️

High sustained virologic response rates in rapid virologic response patients in the large real-world PROPHESYS cohort confirm results from randomized clinical trials ⬇️

Hyaluronic acid levels predict increased risk of non-AIDS death in hepatitis-coinfected persons interrupting antiretroviral therapy in the SMART Study

Hyperglycemia in severe falciparum malaria: a case report

Immune activation and microbial translocation in liver disease progression in HIV/hepatitis co-infected patients: results from the Icona Foundation study

Impact of hepatitis C virus infection on lifestyle

Impact of immunosuppressive therapy on the severity of COVID-19 in solid organ transplant recipients

Impact of lamivudine on the risk of liver-related death in 2,041 HBsAg- and HIV-positive individuals: results from an inter-cohort analysis

Improvement of ALT decay kinetics by all-oral HCV treatment: Role of NS5A inhibitors and differences with IFN-based regimens

Incidence and predictors of single drug discontinuation according to the presence of HCV coinfection in HIV patients from the ICONA Foundation Cohort Study

Incidence and risk factors for liver enzyme elevation during highly active antiretroviral therapy in HIV-HCV co-infected patients: results from the Italian EPOKA-MASTER Cohort

Influence of genotype 3 hepatitis C coinfection on liver enzyme elevation in HIV-1-positive patients after commencement of a new highly active antiretroviral regimen: results from the EPOKA-MASTER Cohort

Italian consensus Guidelines for the management of hepatitis B virus infections in patients with rheumatoid arthritis

Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons

Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update 2011

Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update 2015.

Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update 2016.

Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update December 2014.

Lamivudine or emtricitabine (XTC)/protease inhibitor dual therapy as a harm-reduction strategy in patients with tenofovir-related renal toxicity: A case–control study ⬇️

Liver enzyme elevation during darunavir-based antiretroviral treatment in HIV-1-infected patients with or without hepatitis C coinfection: data from the ICONA foundation cohort

Liver fibrosis, microbial translocation and immune activation markers in HIV and HCV infections and in HIV/HCV co-infection.

Liver stiffness measurement by transient elastography predicts early recovery from acute hepatitis

Management of hepatocellular carcinoma in human immunodeficiency virus-infected patients

Management of infections in cirrhotic patients: report of a consensus conference

Management of infections pre- and post-liver transplantation: report of an AISF consensus conference

Managing hepatitis C virus-HIV liver transplant recipients with the new direct-acting antivirals: are we glimpsing a brilliant future behind our shoulders?

Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies

Natural history of chronic hepatitis B in co-infected patients.

Natural history of compensated viral cirrhosis in a cohort of patients with HIV infection

News on Viral Hepatitis in HIV: Update from the 2016 GEHEP Conference

Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study

Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir Combination Treatment in Patients with HIV/HCV Co-Infection: Results of an Italian Compassionate Use Program

Opportunistic disease and mortality in patients coinfected with hepatitis B or C virus in the strategic management of antiretroviral therapy (SMART) study

Optimization of hepatitis C virus screening strategies by birth cohort in Italy

Optimizing treatment in HIV/HCV coinfection

Pathogenesis of liver damage in HCV-HIV patients.

Persistent positivity and fluctuations of SARS-CoV-2 RNA in clinically-recovered COVID-19 patients

Prevalence of Single and Multiple Natural NS3, NS5A and NS5B Resistance-Associated Substitutions in Hepatitis C Virus Genotypes 1-4 in Italy

Prise en charge de l’infection par le virus de l’hépatite B chez les patients atteints de polyarthrite rhumatoïde : conférence de consensus italienne

Prognostic Value of the Fibrosis-4 Index in Human Immunodeficiency Virus Type-1 Infected Patients Initiating Antiretroviral Therapy with or without Hepatitis C Virus

Quantification of 1,3-β-D-Glucan by Wako β-Glucan Assay for rapid exclusion of invasive fungal infections in critical patients: a diagnostic test accuracy study